Tissue selective affinity targeting using the avidin-biotin system

Drug Development Research

Volumn 50, Issue 3-4, 2000, Pages 258-271

  Chen, Limor ^a   Schechter, Bilha ^a   Arnon, Ruth ^a   Wilchek, Meir ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

Avidin; Biotin; Streptavidin; Targeting; Tissue markers

Indexed keywords

AVIDIN; BIOTIN; CISPLATIN; FLUOROURIDINE; STREPTAVIDIN;

ACTIVE TRANSPORT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; BINDING AFFINITY; BINDING SITE; CYTOTOXICITY; DRUG DELIVERY SYSTEM; LIGAND BINDING; LIVER CELL; MOUSE; NONHUMAN; PROTEIN BINDING; PROTEIN DEGRADATION; REVIEW; SOLID TUMOR; TARGET CELL; TARGET ORGAN; THERMODYNAMICS;

EID: 0033809518     PISSN: 02724391     EISSN: None     Source Type: Journal    
DOI: 10.1002/1098-2299(200007/08)50:3/4<258::AID-DDR9>3.0.CO;2-A     Document Type: Review

References (67)

1. Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model
2. Molecular cloning and nucleotide sequence of the streptavidin gene
3. Carbohydrate specific receptors in the liver
4. Affinity cleavage and targeted catalysis of proteins using the avidin-biotin system
5. Endothelial leukocyte adhesion molecule 1: An inducible receptor for neutrophils related to complement regulatory proteins and lectins
6. NG2 proteoglycan-binding peptides target tumor neovasculature
7. The properties of streptavidin, a biotin-binding protein produced by streptomyces
8. Three-step radioimmunotherapy with yttrium-90 biotin: Dosimetry and pharmaco-kinetics in cancer patients
9. The role of polymer conjugates in the diagnosis and treatment of cancer
10. Limited proteolysis of native proteins: The interaction between avidin and proteinase K
11. Kupffer cells recognize trinitrobenzene-labeled erythrocytes
12. Control of in vivo fate of albumin derivatives utilizing combined chemical modification
13. Avidin
14. Hepatic targeting of drugs and proteins by chemical modification
15. Enhanced turnout growth in the rat liver after selective elimination of Kupffer cells
16. Studies on the biotin-binding site of avidin
17. Soluble macromolecules as carriers for daunorubicin
18. A conjugate of 5-fluorouridine-poly (L-lysine) and an antibody reactive with human colon carcinoma
19. Cloning of GMP-140, a granulate membrane protein of platelets and endothelium: Sequence similarity to proteins involved in cell adhesion and inflammation
20. Antibody-dependent signal amplification in tumor xenografts after pretreatment with biotinylated monoclonal antibody and avidin or streptavidin
21. Tumor angiogenesis: Past, present and the near future
22. Anticancer drug targets: Approaching angiogenesis
23. Molecular structure of human lymphocyte receptor for immunoglobulin E
24. Tumor targeting with a selective gelatinase inhibitor
25. Cloning of a lymphocyte homing receptor reveals a lectin
26. Enhanced biochemical affinities of multivalent neoglycoconjugates
27. Renal filtration, transport and metabolism of low molecular weight proteins: A review
28. Extremely rapid endocytosis, mediated by mannose receptor of sinusoidal endothelial rat liver cells
29. Galactosylated streptavidin for improved clearance of biotinylated intact and F(ab')2 fragments of an anti tumor antibody
30. A new concept for macromolecular therapeutics in cancer chemotherapy: Mechanism of tumoritropic accumulation of proteins and antitumor agent Smancs
31. An electron microscopy study of Kupffer cells in livers of mice having Friend erythroleukemia hepatic metastases
32. Human and murine Kupffer cell function may be altered by both intrahepatic and intrasplenic tumor deposits
33. Characterization and biological implications of membrane lectins in tumor, lymphoid and myeloid cells
34. Glycoconjugates as carriers for specific delivery of therapeutic drugs and genes
35. Streptavidin facilitates internalization and pulmonary targeting of an anti-endothelial cell antibody (platelet-endothelial cell adhesion molecule 1): A strategy for vascular immunotargeting of drugs
36. Blocking of CD4 cell receptors for human immunodeficiency virus type 1 (HIV-1) by chemically modified bovine milk proteins: Potential for AIDS prophylaxis
37. In vitro and in vivo evaluation of streptavidin immunoconjugates of the second generation TAG-72 monoclonal antibody CC49
38. Carboxylases and the role of biotin
39. Angiostatin induces and sustains dormancy of human tumors in mice
40. Organ targeting in vivo using phage display peptide libraries
41. Aminopeptidase N is a receptor for tumor-homing peptides and a target for inhibiting angiogenesis
42. Iodine-131 and indium-111 labelled avidin and streptavidin for pre-targeted immunoscintigraphy with biotinylated anti-tumour monoclonal antibody
43. Selective liver targeting of antivirals by recombinant chylomicruns - A new therapetic approach to hepatitis B
44. Cis-platinum(II) complexes of carboxymethyl-dextran as potential antitumor agents. I. Preparation and characterization
45. Cis-platinum(II) complexes of carboxymethyl-dextran as potential antitumor agents. II. In vitro and in vivo activity
46. Soluble polymers as carriers of cis-platinum
47. Blood levels and serum protein binding of cis-platinum (II) complexed to carboxymethyl-dextran
48. Tissue distribution of avidin and streptavidin injected to mice
49. Indirect immunotargeting of cis-Pt to human epidermoid carcinoma KB using the avidin biotin system
50. Cytotoxicity of streptavidin-blocked biotinyl-ricin is retrieved by in vitro immunotargeting via biotinyl monoclonal antibody
51. Renal accumulation of streptavidin: Potential use for targeted therapy to the kidney
52. Polymers in drug delivery: Immunotargeting of carrier-supported cis-platinum complexes
53. Liver accumulation of TNP modified streptavidin and avidin: Potential use for targeted radio- and chemotherapy
54. Organ selective delivery using a tissue directed streptavidin-biotin system: Targeting 5-fluorourouridine via TNP-streptavidin
55. The hepatic asialoglycoprotein receptor
56. Fluorouridine-anti-CEA immunoconjugate is therapeutically effective in a human colonic cancer xenograft model
57. Contribution to ligand binding by multiple carbohydrate-recognition domain in the macrophage mannose receptor
58. -furanidyl-5-fluorouracil)
59. Liposome-incorporated 3', 5'-O-dipalmitol 5-fluoro-2'-deoxyuridine as a slow-release anti-tumor drug depot in rat liver macrophages
60. Pharmacokinetics of 5-fluorouracil assessed with a sensitive mass spectrometric method in patients on a dose escalation schedule
61. Receptor mediated glycotargeting
62. The avidin-biotin complex in bioanalytical applications
63. Avidin-biotin technology: Has it lived to its expectations?
64. Introduction to avidin-biotin technology, etc.
65. Avidin targeting of intraperitoneal tumor xenografts
66. Evidence of direct interaction between Kupffer cells and colon cancer: An ultrastructural study of the co-culture
67. Intravenous avidin chase improved localization of radiolabeled streptavidin in intraperitoneal xenograft pretargeted with biotinylated antibody